David Rosenberg, Gluskin Sheff’s chief economist, said the recent stock rebound is a classic bear market rally. » Read More
Head of policy research at Strategas Research Partners Dan Clifton says the government shutdown will not lead to negative growth in the first quarter. » Read More
Jim O'Neill, former chairman at Goldman Sachs Asset Management, commented on Brexit and the future of the EU. » Read More
Wells Fargo Securities analyst Mike Mayo says the 'boogeyman' is not coming for the banks.
Keith Parker, head of U.S. equity strategy at UBS, said an earnings recession is unlikely this year.
Francisco Blanch, head of global commodity and derivatives research at Bank of America Merrill Lynch Global Research, said oil prices are likely to head higher this year.
Ruchir Sharma, chief global strategist and head of emerging markets at Morgan Stanley Investment Management, said the U.S. economy has peaked.
Bruce Bittles, chief investment strategist at Baird, said the trade talks between Washington and Beijing are the most important driver on the stock market.
Jim Suva, Citi's senior tech analyst, said the trade war is hurting tech sector as it causes delays in spending.
John Sculley, former Apple CEO, said health tech is next big movement in the industry.
Barry James, president and portfolio manager at James Investment Research talks about the Fed's plans for future rate hikes and what they could mean for stocks.
Here's the full interview with Mohamed El-Erian, chief economic advisor at Allianz, on recession fears and the Federal Reserve outlook.
Cigarette company Altria is poised for rockier times as tobacco sales slow, according to Cowen's Vivien Azer.
Gluskin Sheff's David Rosenberg on the Federal Reserve's tightening plan and how it could hurt GDP.
Head of Policy Research at Strategas Dan Clifton joins "The Exchange" to talk U.S.-China trade relations.
Toni Sacconaghi, senior research analyst at Sanford C. Bernstein, sees the longer iPhone lifespan as Apple's biggest challenge.
Here's the full interview with Pierre Ferragu at New Street Research, who upgraded Apple amid China worries.
Jeremy Siegel, professor of finance at Wharton School at The University of Pennsylvania, said stocks could rally up to 15 percent in the new year.
David Lebovitz, global market strategist at JP Morgan Asset Management, said the markets will be choppier in 2019.
UBS initiated its rating for CVS Health at buy on Thursday, saying the opportunity is "too good to pass up."
Gluskin Sheff’s David Rosenberg said the recent stock rebound is a classic bear market rally.
Dan Clifton of Strategas Research, says the government shutdown will not lead to negative growth in the first quarter.